Literature DB >> 2500046

Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy.

R Ullrich1, M Zeitz, W Heise, M L'age, G Höffken, E O Riecken.   

Abstract

STUDY
OBJECTIVE: To determine small intestinal mucosal structure and function in patients with human immunodeficiency virus (HIV) infection.
DESIGN: Prospective, consecutive sample study.
SETTING: Referral-based medical clinics at a municipal and a university medical center. PATIENTS: Forty-five HIV-infected patients (44 men, 1 woman) with gastrointestinal complaints.
INTERVENTIONS: All patients had esophagogastroduodenoscopy. Distal duodenal biopsy samples were examined morphometrically and by quantitative enzyme histochemical techniques. Immunohistologic studies were done to determine whether HIV antigen p24 was present. Biopsy and stool samples were examined for enteric pathogens and patients were evaluated for malabsorption.
MEASUREMENTS AND MAIN RESULTS: Malabsorption was common in HIV-infected patients. In 15 of 38 patients mononuclear cells infected with HIV were found in the mucosa. In 15 of 25 patients there was no detectable lactase (beta-glucosidase) activity in the duodenal brush border; when measurable, lactase (beta-glucosidase) activity was decreased (P less than 0.02). Alkaline phosphatase activity was normal. Crypt depth was greater (P less than 0.05), villous surface area was slightly smaller, and mitotic figures per crypt were not different in HIV-infected patients compared with controls. Patients without additional intestinal infection had a reduced number of mitotic figures per crypt (P less than 0.05) and normal crypt depth. The reduction in mitotic figures was most pronounced in patients with mucosal HIV antigen p24.
CONCLUSIONS: The HIV-infected patients with gastrointestinal symptoms show low-grade small bowel atrophy and a maturational defect in enterocytes, which may be caused exclusively by HIV. An additional intestinal infection can mask this mucosal atrophy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500046     DOI: 10.7326/0003-4819-111-1-15

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  66 in total

1.  Pharmacokinetics of rifabutin in HIV-infected patients with or without wasting syndrome.

Authors:  G Gatti; A Di Biagio; C R De Pascalis; M Guerra; M Bassetti; D Bassetti
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

2.  Lack of evidence for small intestinal mucosal T-cell activation as a pathogenic mechanism in African HIV-associated enteropathy.

Authors:  A M Veitch; P Kelly; I Zulu; T T MacDonald; M J Farthing
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

3.  Introduction: a welcome to the First Special Animal Health Issue of AAPS PharmSci.

Authors:  Marilyn Martinez; Stefan Soback
Journal:  AAPS PharmSci       Date:  2002

4.  HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report.

Authors:  Brandi Giovanni; Carlo Calabrese; Roberto Manfredi; Anna Maria Pisi; Giulio Di Febo; Rossella Hakim; Giovanna Cenacchi; Guido Biasco
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

Review 5.  Human immunodeficiency virus-induced enteropathy.

Authors:  R Ullrich; E O Riecken; M Zeitz
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 6.  An approach to duodenal biopsies.

Authors:  S Serra; P A Jani
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

Review 7.  Pathogenesis of HIV in the gastrointestinal tract.

Authors:  Satya Dandekar
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

Review 8.  Role of cytokines in infectious and noninfectious enteropathy in patients with AIDS.

Authors:  P D Smith
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

9.  Isolation of human immunodeficiency virus type 1 (HIV-1) RNA from feces by a simple method and difference between HIV-1 subpopulations in feces and serum.

Authors:  L van der Hoek; R Boom; J Goudsmit; F Snijders; C J Sol
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

10.  Gastrointestinal symptoms in ambulatory HIV-infected patients.

Authors:  G R May; M J Gill; D L Church; L R Sutherland
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.